同行支持对护理人员福祉和新生儿重症监护病房患者结果的有效性:系统性审查
Sarah Wegman1, Peter Juviler, Benjamin Coffey
1Author Affiliations: School of Medicine and Dentistry, University of Rochester, Rochester, New York (Ms Wegman); Department of Surgery, University of Rochester, Rochester, New York (Dr Juviler); Department of Medicine, SUNY Upstate Medical University , Syracuse, New York (Mr Coffey); Golisano Children's Hospital, Rochester, New York (Ms Schriefer); and Division of Pediatric Surgery, University of Rochester, Rochester, New York (Dr Wakeman).
同龄人支持计划可以通过减少压力和提高自信来帮助新生儿重症监护室 (NICU) 的婴儿护理人员. 需要进一步的研究来证实新生儿重症监护室护理人员的这些好处.
科学领域:
- 新生儿重症监护室 (NICU) 护理人员支持
- 同行指导的有效性 同行指导的有效性
- 系统审查方法论 系统审查方法论
背景情况:
- 新生儿重症监护室 (NICU) 的护理人员面临重大压力.
- 同行支持计划将新手和经验丰富的护理人员联系起来,以获得教育和情感援助.
研究的目的:
- 系统地审查对婴儿新生儿重症监护室出院后护理人员的同行支持计划的有效性.
- 综合新生儿重症监护室家庭对同行支持干预措施的证据.
主要方法:
- 在PubMed,Embase和Web of Science的系统文献搜索.
- 包括随机,准实验,观察或定性设计的研究.
- 从最初确定的3594个中,分析了7个符合纳入标准的选定文章.
主要成果:
- 所有审查的同行支持计划都改善了护理人员的压力,焦虑,抑郁和愤怒.
- 在护理人员感知的能力,婴儿互动,希望和信心方面注意到了改善.
- 一个随机对照试验发现没有显著的益处;没有研究报告了负面结果.
结论:
- 同行支持显示,在NICU停留后,有潜力提高护理人员的福祉和自我效能.
- 建议进一步进行高质量的研究来验证这些发现.
- 有证据表明,同行支持是NICU护理人员的有价值,低风险的干预措施.
更多相关视频
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
相关概念视频
Patient-centered Care
Nursing Evaluation
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Ethical Issues
Ethical Concerns in Healthcare:
Current Trends in Nursing II
